Header cover image

U.S. Life Sciences Industry Analysis

UpdatedOct 09, 2024
DataAggregated Company Financials
Companies64
  • 7D-2.2%
  • 3M9.0%
  • 1Y13.3%
  • YTD4.0%

Over the last 7 days, the Life Sciences industry has dropped 3.2%, driven by a pullback from Thermo Fisher Scientific of 2.9%. In contrast, Illumina has gained 8.3%. This takes the industry's 12 month performance to a gain of 14%. Earnings are forecast to grow by 18% annually.

Industry Valuation and Performance

Has the U.S. Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 09 Oct 2024US$728.8bUS$141.8bUS$8.5b36.9x85.8x5.1x
Fri, 06 Sep 2024US$734.8bUS$141.8bUS$8.5b37.3x86.5x5.2x
Sun, 04 Aug 2024US$742.2bUS$140.9bUS$11.3b37.3x65.9x5.3x
Tue, 02 Jul 2024US$680.5bUS$141.3bUS$12.2b38.3x55.9x4.8x
Thu, 30 May 2024US$716.0bUS$141.5bUS$12.4b37.5x57.6x5.1x
Sat, 27 Apr 2024US$709.7bUS$141.6bUS$12.7b39.2x55.8x5x
Mon, 25 Mar 2024US$749.2bUS$142.1bUS$12.8b44.7x58.4x5.3x
Wed, 21 Feb 2024US$714.0bUS$142.2bUS$12.5b42.7x56.9x5x
Fri, 19 Jan 2024US$681.8bUS$153.8bUS$14.2b35.4x48.1x4.4x
Sun, 17 Dec 2023US$684.6bUS$153.7bUS$14.2b37.1x48.1x4.5x
Tue, 14 Nov 2023US$581.9bUS$153.8bUS$14.0b31x41.7x3.8x
Thu, 12 Oct 2023US$646.8bUS$154.6bUS$11.2b33.6x57.7x4.2x
Sat, 09 Sep 2023US$705.6bUS$154.6bUS$11.2b31.6x63x4.6x
Mon, 07 Aug 2023US$725.8bUS$154.7bUS$11.3b30.2x64.5x4.7x
Wed, 05 Jul 2023US$691.6bUS$152.4bUS$12.5b29.6x55.3x4.5x
Fri, 02 Jun 2023US$675.5bUS$152.2bUS$12.5b27.2x54x4.4x
Sun, 30 Apr 2023US$699.4bUS$152.9bUS$9.4b29.2x74.1x4.6x
Tue, 28 Mar 2023US$708.5bUS$154.5bUS$10.8b26.2x65.5x4.6x
Thu, 23 Feb 2023US$721.8bUS$154.3bUS$10.9b31.1x66x4.7x
Sat, 21 Jan 2023US$769.6bUS$155.3bUS$8.5b30.9x90.3x5x
Mon, 19 Dec 2022US$742.7bUS$155.2bUS$8.8b28.5x84.6x4.8x
Wed, 16 Nov 2022US$777.2bUS$154.9bUS$8.8b29.1x87.8x5x
Fri, 14 Oct 2022US$705.7bUS$152.5bUS$17.0b23.8x41.5x4.6x
Sun, 11 Sep 2022US$800.8bUS$152.3bUS$17.3b30.6x46.3x5.3x
Tue, 09 Aug 2022US$824.5bUS$151.9bUS$18.2b33.4x45.3x5.4x
Thu, 07 Jul 2022US$731.3bUS$148.1bUS$20.1b30.7x36.4x4.9x
Sat, 04 Jun 2022US$756.2bUS$148.1bUS$20.1b31.2x37.6x5.1x
Mon, 02 May 2022US$777.1bUS$150.9bUS$21.1b31.2x36.8x5.1x
Wed, 30 Mar 2022US$871.0bUS$146.0bUS$25.4b37.3x34.3x6x
Fri, 25 Feb 2022US$833.4bUS$146.2bUS$25.3b37x32.9x5.7x
Sun, 23 Jan 2022US$836.8bUS$138.0bUS$27.3b39.3x30.6x6.1x
Tue, 21 Dec 2021US$958.1bUS$138.0bUS$27.3b43.5x35.1x6.9x
Thu, 18 Nov 2021US$971.5bUS$137.8bUS$27.1b47.9x35.8x7.1x
Sat, 16 Oct 2021US$714.0bUS$106.0bUS$18.5b46.4x38.5x6.7x
Price to Earnings Ratio

38.5x


Total Market Cap: US$714.0bTotal Earnings: US$18.5bTotal Revenue: US$106.0bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Life Sciences Industry Price to Earnings3Y Average 54.6x202220232024
Current Industry PE
  • Investors are optimistic on the American Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 86.4x which is higher than its 3-year average PE of 54.6x.
  • The industry is trading close to its 3-year average PS ratio of 5.1x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have declined 23% per year over the last three years.
  • Meanwhile revenues for these companies have grown 10% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market0.57%
Healthcare-0.80%
Life Sciences-2.17%
Clinical Research and Equipment-2.17%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ILMN IlluminaUS$139.668.3%
+US$1.7b
0.6%PS5x
ICLR ICONUS$287.561.1%
+US$252.6m
18.4%PE33.3x
MEDP Medpace HoldingsUS$338.161.4%
+US$145.7m
37.2%PE30.8x
BIO Bio-Rad LaboratoriesUS$339.220.5%
+US$42.6m
-7.1%PS3.7x
WAT WatersUS$358.910.2%
+US$34.4m
33.5%PE35.8x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

MTD

US$1,451.47

Mettler-Toledo International

7D

-1.8%

1Y

32.3%

WAT

US$358.91

Waters

7D

0.2%

1Y

33.5%

WST

US$286.48

West Pharmaceutical Services

7D

-4.4%

1Y

-26.0%

ILMN

US$139.66

Illumina

7D

8.3%

1Y

0.6%

LFCR

US$4.81

Lifecore Biomedical

7D

-0.8%

1Y

-34.0%

A

US$144.61

Agilent Technologies

7D

-1.3%

1Y

27.6%

ICLR

US$287.56

ICON

7D

1.1%

1Y

18.4%

MEDP

US$338.16

Medpace Holdings

7D

1.4%

1Y

37.2%

TEM

US$48.08

Tempus AI

7D

-9.4%

1Y

n/a

SYNH

US$42.98

Syneos Health

7D

0.6%

1Y

-8.8%